Research focus: Oxidative-stress models, inflammatory signaling, mitochondrial function readouts, and glutathione-dependent enzymatic pathways
They promise: A quick 2-minute eligibility quiz No insurance required $249/month pricing (no matter the dose) Fast approval and delivery Everything is online, and they ship to all 50 states
The trial enrolled 281 participants across 42 research and healthcare centers in the United States, randomized to once-weekly subcutaneous retatrutide (0.5, 4, 8, or 12 mg), once-weekly subcutaneous dulaglutide 1.5 mg (active comparator), or placebo, over a 36-week treatment period
You should then wait at least 30 minutes before eating, drinking or taking other oral medicines